In this segment, Jeffrey Lancet, MD; Mark R. Litzow, MD; Raoul Tibes, MD; and Dan Douer, MD, describe factors that help determine the prognosis of individuals ...
Journal of Hope - Teri Powell: When Chronic Meets Courage
At 23, Teri Powell learned she had chronic myelogenous leukemia (CML). While her friends established careers, homes, and relationships, Teri navigated ...
ASH12: Experimental Ponatinib Overcomes Drug Resistance in CML
Discontinuation of Treatment With TKIs in Chronic Myelogenous Leukemia
In this segment, the panelists discuss whether or not the administration of BCR-ABL-targeted TKIs should ever be stopped for patients with CML experiencing a ...
Supportive Care for CLL - Mayo Clinic
Chronic lymphocytic leukemia, or CLL, can make survivors more susceptible to other forms of cancer and other conditions. In this video, Dr. Tait Shanafelt, ...
Dr. Jennifer Brown on Mutations and Targets in CLL
Jennifer Brown, MD, PhD, Director, Chronic Lymphocytic Leukemia Center, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical ...
Acute lymphoblastic leukemia ( ALL )
I describe briefly the experience I went through starting , Nov 14, 12 . I made this video 5/22/14, if anyone has a question they think I might be able to help them ...
Hello. I am 48 years old and was diagnosed with ALL in October, 2014. It
sounds like you are doing pretty well considering all of the treatments.
Did you complete 5 or 8 treatments? My doctors are telling me I need all
8 and then they will do the next bone marrow check.
GIST: Assessing Response to Imatinib Therapy
Syma Iqbal, MD; Anthony P. Conley, MD; and Robert H. I. Andtbacka, MD, examine the role of tyrosine kinase inhibitor, imatinib, as adjuvant treatment of ...
Acute myeloblastic leukemia with maturation (Medical Condition)
Symptoms, risk factors and treatments of Acute myeloblastic leukemia with maturation (Medical Condition) M2 is a subtype of AML This video contains general ...